AUSTRIA – Atlas co-leads EUR 14m ProtAffin financing

The company raised a EUR 4m Series-A financing round in 2007, which was led by Aescap Venture Management. ProtAffin has also raised EUR 2m in non-dilutive financing in Austria in seed finance and product development grants.

ProtAffin AG develops biopharmaceutical products that act by targeting cell-surface glycan structures that target inflammation and oncology. The company currently has 16 employees in its offices and labs in Graz and a corporate office in Vienna. ProtAffin plans to increase head-count to 27 by the end of 2009.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH